Shares of Arteris, Inc. (NASDAQ:AIP – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $37.29.
AIP has been the topic of a number of recent analyst reports. Craig Hallum started coverage on Arteris in a research note on Monday, September 21st. They set a “buy” rating and a $30.00 target price on the stock. Rosenblatt Securities reaffirmed a “buy” rating and issued a $38.00 price target on shares of Arteris in a report on Friday, August 7th. TD Cowen decreased their target price on Arteris from $40.00 to $25.00 and set a “buy” rating on the stock in a research note on Monday, October 19th. Weiss Ratings upgraded shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Finally, Jefferies Financial Group raised Arteris from a “hold” rating to a “buy” rating and increased their price objective for the company from $35.00 to $50.00 in a research note on Friday, August 7th.
Check Out Our Latest Stock Analysis on AIP
Arteris Stock Performance
AIP opened at $19.06 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. The company has a market capitalization of $936.80 million, a PE ratio of -21.91 and a beta of 1.90. The business has a fifty day simple moving average of $22.40 and a 200 day simple moving average of $28.94. Arteris has a 1 year low of $12.06 and a 1 year high of $50.26.
Arteris (NASDAQ:AIP – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%. The business had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. Research analysts expect that Arteris will post -0.68 EPS for the current year.
Insider Activity at Arteris
In related news, CEO K Janac sold 100,000 shares of Arteris stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $20.75, for a total transaction of $2,075,000.00. Following the completion of the transaction, the chief executive officer directly owned 8,229,071 shares of the company’s stock, valued at $170,753,223.25. This trade represents a 1.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 100,000 shares of Arteris stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $20.75, for a total value of $2,075,000.00. Following the completion of the transaction, the insider directly owned 8,229,071 shares of the company’s stock, valued at approximately $170,753,223.25. This represents a 1.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 752,631 shares of company stock worth $19,147,283 over the last ninety days. Corporate insiders own 23.30% of the company’s stock.
Institutional Trading of Arteris
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Versant Capital Management Inc grew its holdings in Arteris by 33.7% during the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after buying an additional 290 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of Arteris by 106.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock valued at $41,000 after buying an additional 890 shares during the last quarter. Sterling Capital Management LLC lifted its holdings in Arteris by 612.5% during the third quarter. Sterling Capital Management LLC now owns 1,197 shares of the company’s stock valued at $28,000 after purchasing an additional 1,029 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Arteris during the 2nd quarter valued at $53,000. Finally, Nisa Investment Advisors LLC boosted its stake in Arteris by 55.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 4,714 shares of the company’s stock worth $111,000 after purchasing an additional 1,690 shares during the period. 64.36% of the stock is currently owned by institutional investors and hedge funds.
About Arteris
Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.
The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.
See Also
- Five stocks we like better than Arteris
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
